TOVX vs WTW · rev $300.0K vs P/E 15, rev $4.88B
Theriva Biologics Inc. (TOVX) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Theriva Biologics Inc. (TOVX) is a biotechnology company listed on NYSE MKT.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported TOVX revenue for 2026-06-30 was $300.0K. Net income was -$5.3M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. TOVX currently screens at market cap $12.4M.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
TOVX currently screens at market cap $12.4M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the TOVX and WTW stock pages for the full models.
Not investment advice.